Absci Corporation
Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All ABSI news ›Absci (NASDAQ:ABSI) Stock Jumps 13.2% - Still a Buy?
Absci Corporation (NASDAQ:ABSI - Get Free Report)'s stock price was up 13.2% on Friday. The company traded as high as $9.30 and last traded at $10.12. 297,880 shares changed hands during mid-day trading, a decline of 93% from the average…
Critical Contrast: Absci (NASDAQ:ABSI) and Black Diamond Therapeutics (NASDAQ:BDTX)
Black Diamond Therapeutics (NASDAQ:BDTX – Get Free Report) and Absci (NASDAQ:ABSI – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of…
PacBio Deepens AI Drug-Discovery Push With TychoBio Deal — PACB Stock Takes A Breather After 103% Rally
PacBio (PACB) was on investors’ radar on Tuesday after the biotech firm announced a partnership with TychoBio, pushing it deeper into AI-based drug discovery. After an eight-session rally that more than doubled its value, PACB shares…
QIAGEN Expands AI-Powered Bioinformatics for Research and Drug Discovery
QIAGEN (NYSE: QGEN) introduced IPA Investigator and the QIAGEN Discovery Platform to expand AI capabilities in research and drug discovery. VENLO, Netherlands & GERMANTOWN, Md.--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime…
DeepMind unveils AI system that designs enzymes no living cell ever made
Google DeepMind's AlphaProtein Novo preprint, released October 5, pairs with work from the Francis Crick Institute and builds on the AlphaFold lineage behind spinout Isomorphic Labs, which raised $2.1 billion this year. Google DeepMind…
Annovis turns to AI to fast-track its Alzheimer’s filing
The paperwork is a part of drug development that almost never makes headlines. A New Drug Application to the Food and Drug Administration (FDA) can run to hundreds of thousands of pages, stitching together years of trial data, safety…
Kymanox Launches KymaBridge, an Intelligence Platform Connecting Pharma and Biotech Innovators with Drug Delivery Device Technologies
New platform pairs Kymanox subject matter expert verification with supplier-confirmed data, helping sponsors identify the right drug delivery device technology faster, while giving device suppliers a direct, verified channel to showcase…
BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global Pharmaceutical in Major Depressive Disorder
How this balance works Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side…
Absci Corporation (NASDAQ:ABSI) Stock Has Average Target Price of $13.71
Check Out Our Latest Report on Absci Shares of ABSI opened at $11.07 on Friday. The company has a 50-day moving average of $9.02 and a two-hundred day moving average of $7.12. The stock has a market cap of $1.90 billion, a…
PharmTech AI Pulse Check: Episode 2 - Shadow AI, Trade Secrets, the API Race
PharmTech.com
From articles in the 4Search news index.